# Clinical Trial to Investigate CT38 in the Treatment of Myalgic Encephalomyelitis / Chronic Fatigue Syndrome

> **NCT03613129** · PHASE1,PHASE2 · COMPLETED · sponsor: **LUCINDA BATEMAN, MD** · enrollment: 17 (actual)

## Conditions studied

- Myalgic Encephalomyelitis
- Chronic Fatigue Syndrome

## Interventions

- **DRUG:** CT38

## Key facts

- **NCT ID:** NCT03613129
- **Lead sponsor:** LUCINDA BATEMAN, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-07-23
- **Primary completion:** 2019-04-30
- **Final completion:** 2019-04-30
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2020-05-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03613129

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03613129, "Clinical Trial to Investigate CT38 in the Treatment of Myalgic Encephalomyelitis / Chronic Fatigue Syndrome". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT03613129. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*